Kirson Eilon D. 4
4 · NovoCure Ltd · Filed Mar 1, 2019
Insider Transaction Report
Form 4
NovoCure LtdNVCR
Kirson Eilon D.
Chief Science Officer
Transactions
- Exercise/Conversion
Restricted Stock Units
2019-02-27−6,945→ 13,888 totalExercise: $0.00From: 2019-02-27→ Ordinary Shares (6,945 underlying) - Exercise/Conversion
Ordinary Shares
2019-02-27$52.90/sh+6,945$367,391→ 152,408 total
Footnotes (1)
- [F1]Fully vested as of the date hereof.